NYSE ARCA | ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy.
It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index.
The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.74% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.68% |
ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.67% |
INSM | Insmed Inc | Healthcare | Biotechnology | 2.61% |
EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.59% |
UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 2.57% |
NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.57% |
GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.54% |
AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 2.43% |
INCY | Incyte Corporation | Healthcare | Biotechnology | 2.33% |
BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.31% |
MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 2.27% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.26% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 2.23% |
BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 2.15% |
EXEL | Exelixis Inc | Healthcare | Biotechnology | 2.11% |
MRNA | Moderna Inc | Healthcare | Biotechnology | 2.00% |
BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.98% |
BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 1.74% |
TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 1.73% |